Bayer Advances Research for Pulmonary Hypertension

Bayer HealthCare works with the Ludwig Boltzmann Institute (LBI) for Lung Vascular Research in the research area of lung vascular diseases.

Bayer HealthCare is working with the Ludwig Boltzmann Institute (LBI) for Lung Vascular Research in the research area of lung vascular diseases - especially pulmonary hypertension. Other partners include the German medical device manufacturer NEBU-Tec and the Austrian Academy of Sciences.

The research facility is also sponsored by Bayer and belongs to the Ludwig Boltzmann Gesellschaft (LBG). The LBI for Lung Vascular Research is located at the Medical University of Graz, which is also a partner of the LBI.

Pulmonary hypertension (PH) is a disorder in which the pressure in the pulmonary arteries is above normal. The most common symptoms of PH include shortness of breath, fatigue, dizziness and fainting, all of which are worsened by exertion.